Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. How common it is

Topic: Brain proteins, microglia and lab models

Spatial omics enables the integration of high-dimensional molecular organization with clinical outcomes, yet incorporating spatial single-cell information into predictive models at the population scale remains challenging. Here, we introduce SPIN (Spatial Predictive Integration Network), which integrates subject-specific, spatially informed co-expression or co-abundance networks for population-scale clinical prediction. Current implementation of SPIN includes three key modules: network construction, molecular-to-clinical prediction by Bayesian scalar-on-network regression with manifold learning (BSNMani), and visualization & interpretation module. In the SEA-AD MERFISH transcriptomics cohort, SPIN framework achieved an accuracy of 0.81 for dementia-status prediction and revealed gene-gene co-expression subnetworks with clear biological relevance, such as glutamatergic synapses- and neurogenesis-related subnetworks. SPIN also achieved robust survival prediction in a breast cancer single proteomics cohort (C-index=0.78), identifying two survival-associated spatial proteomic subnetworks. SPIN can further use cell-type-specific spatial omics data to enhance the granularity. In summary, SPIN is a valuable tool that uses high-dimensional spatial omics data for clinical outcome prediction at the population scale across diverse disease settings, revealing biological insights while maintaining interpretation. SPIN package is available at: https://github.com/lanagarmire/SPIN

Key findings

Why it matters

This study introduced a tool called SPIN that uses spatial omics data to predict dementia status and find related gene networks. It is a technical method for research and prediction, not a treatment, cure, or prevention for Alzheimer's disease.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 3 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 24 of the 94 points it could be judged on, which is 26 of 100. Raw total 26 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 26 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 26 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 24 of the 94 points we could judge it on, which is 26 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Lana X. Garmire: h-index 19 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 24 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 24 of the 94 points we could judge it on is 26 out of 100.
Total 26 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

APA 7th

Liu, T., Ko, E., Yang, Y., Wu, H., Unjitwattana, T., Wang, S., et al. (2026). Population-Scale Integration of Spatial Omics Networks for Clinical Prediction and Biological Discovery by SPIN. medRxiv (preprint). https://doi.org/10.1101/2025.08.09.25333297

Vancouver

Liu T, Ko E, Yang Y, Wu H, Unjitwattana T, Wang S, et al. Population-Scale Integration of Spatial Omics Networks for Clinical Prediction and Biological Discovery by SPIN. medRxiv (preprint). 2026. doi:10.1101/2025.08.09.25333297.

BibTeX

@article{liu2026-47e80dff,
  author  = {Liu, T. and Ko, E. and Yang, Y. and Wu, H. and Unjitwattana, T. and Wang, S. and Kang, J. and Li and others},
  title   = {{Population-Scale Integration of Spatial Omics Networks for Clinical Prediction and Biological Discovery by SPIN}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.1101/2025.08.09.25333297},
  url     = {https://doi.org/10.1101/2025.08.09.25333297}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in How common it is

Also in How common it is

80 studies in the library are filed under How common it is with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The How common it is hub.

Similar studies

More on How common it is

See all studies in How common it is →